Skip to main content
Caplight Logo









Lucia Bio

Lucia Bio

Private
BrisbaneAI, Data & Cloud Infrastructurehttps://link.me/lululucyy

Last Round

Seed

Aug 19, 2025

Total Funding Raised

$2.01M

Company Overview

Lucia Bio is a biotechnology company developing next-generation selective spleen tyrosine kinase (Syk) inhibitors for the treatment of peripheral autoimmune diseases, neuroinflammatory disorders, and hematologic malignancies.

Sector

AI, Data & Cloud Infrastructure

Verticals

NLP & Conversational AI, Decentralized Storage, Blockchain Infrastructure, Data Protection, Cloud Infrastructure

Business Model

B2C

Customer Profile

Usage-Based SaaS, Subscription SaaS, Freemium

AI Layer

Application

Keywords

AI agentdecentralized AIpersonal AI assistantprivacy-preserving AIAI copilotsovereign AIDePINdecentralized computeretrieval-augmented generationRAGblind computationautonomous agentWeb3 AIdecentralized storageon-chain analysisutility tokentrusted execution environmentsTEE

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lucia Bio Comparables

Compare Lucia Bio with similar companies based on industry and business-model similarity.

Lucia Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Luzia
76%
MyShell
67%
Alphabet Inc.
62%

Lucia Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 19, 2025

Key People

Founding team and executive leadership

Jonathan Spangler

Chief Executive Officer

Executive Team

Lucia Bio Investors

Notable investors and investment history

Lucia Bio investors
InvestorRounds
UniQuest Pty LtdSeed
UniseedSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 19, 2025

    $2M round led by UniQuest Extension Fund and Uniseed.

Lucia Bio Filings

Explore SEC and related filing metadata, where available.

Lucia Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Lucia Bio's valuation, stock price, and market status.

Is Lucia Bio a public or private company?

Lucia Bio is a private company.

What is the current stock price of Lucia Bio?

Lucia Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Lucia Bio worth (valuation)?

Valuation information for Lucia Bio is not publicly available.

Can I buy Lucia Bio stock?

Lucia Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Lucia Bio's last funding round?

Lucia Bio's most recent funding round was Seed on August 19, 2025.

Who are the main investors in Lucia Bio?

Key investors in Lucia Bio include UniQuest Pty Ltd, Uniseed.

Will Lucia Bio IPO soon?

No public IPO plans have been announced for Lucia Bio.

How can I track Lucia Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lucia Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBrisbane
Employee Range7
Year Founded2024
Last FundingAug 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?